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bound to a Zn2+ near the active site was postulated to play
a significant role in the biosynthetic transformation [17].
The recently published X-ray structure of the first Mg2+-
containing PBGS clearly shows that Mg2+ plays a different
role than Zn2+. The Mg2+ is not present at the active site
but is bound at the interface of the dimer. It has been sug-
gested that Mg2+ exercises its allosteric rate enhancement
using a structure-based mechanism [20]. 
Different mechanisms have been proposed for this seem-
ingly simple Knorr-type condensation [21]. Nandi and
Shemin [14] first postulated a mechanism that is analo-
gous to the reaction catalyzed by the class I aldolases, and
this mechanism became widely accepted [22].
Several years later Jordan and Seehra [23] determined
that the first ALA recognized by the enzyme forms the
propionic acid sidechain in the final product (the P-side of
the product is recognized by the P-site of the enzyme;
Figure 2) using an elegant pulse-labeling experiment with
[5-14C]ALA. This finding was in contrast to the sequence
of recognition events postulated by Nandi and Shemin
[14]. Following Schiff base formation between the
enzyme and the P-side ALA, Jordan and Seehra [23] pos-
tulated that the first connection between the P-side and
the A-side ALA is formed by a carbon–nitrogen bond,
leading to intermediate 4 (Figure 2). This sequence of
recognition events for the two substrates, as well as the
first connecting step, had already been suggested by
Granick and Mauzerall [24]. A mechanistic alternative that
follows more closely the second part of Nandi and Shem-
in’s proposal [14] and involves intermediate 5 formed by
an aldol type reaction was also proposed [3,5] (Figure 2). It
has been difficult to prove either mechanism until now. 
Our group has been investigating the mechanism of PBGS
using systematic inhibition studies for several years [9,25].
To test the recognition sites of Escherichia coli [9] and
Rhodobacter spheroides [25] PBGSs, a series of substrate,
product and postulated intermediate analogs were synthe-
sized and their inhibition potencies determined. The goal
of these investigations was to contribute to our knowledge
about the active site of the enzyme, to elucidate possible
Figure 1
The asymmetric enzymatic synthesis of porphobilinogen (PBG) from
two molecules of 5-aminolevulinate (ALA). The biochemical
transformation corresponds to a Knorr-type pyrrole synthesis during
which two molecules of H2O are eliminated. In aqueous solution ALA
is present mainly as neutral zwitterion, in contrast to the PBG product,
which is negatively charged. The chemical dimerization of ALA under
aerobic conditions leads to the formation of the pyrazine 3. During this
transformation two molecules of H2O are eliminated, but the oxidation
of the dihydropyrazine to the pyrazine by the formal elimination of one
H2 molecule is essential to obtain the stable aromatic heterocycle 3.
Figure 2
The key steps for the enzymatic
transformation of ALA to PBG. For simplicity,
the two mechanisms have been designated
Jordan I and Jordan II. The two substrates are
identified by their position in the final PBG
product. The A-side is the acetic acid
sidechain of PBG (the ALA that becomes the
acetic acid sidechain is recognized by the
A-site of the enzyme), and the P-side is the
propionic acid sidechain (the enzyme’s P-site
recognizes the ALA molecule that becomes
the P-side of PBG). Based on Jordan’s pulse-
labeling experiments, the P-side substrate
forms the first Michaelis–Menten complex with
the enzyme. The ‘first’ substrate is red and all
the structures derived from the P-side
substrate are also red. The two mechanistic
proposals for the enzymatic transformation
differ in the sequence of the bond-forming
steps. In one mechanism (Jordan I), the Schiff
base formation is the first step that connects
the two substrates (4). In the second
mechanism (Jordan II), which is closely related
to the initial proposal of Shemin, an aldol-type
reaction is postulated as the key step (5).
Both mechanisms had been analyzed in
comparison to the two class of aldolases
(aldolase I and II).
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mechanisms for the transformation and to analyze the dif-
ferences between enzymes from different sources.
In recent years, several groups have contributed signifi-
cantly to our knowledge in this field [26–28]. Because
several recombinant enzymes are now available in large
quantities, more systematic studies are possible. The
behavior of the enzymes from E. coli, Saccharomyces cerevisiae
and Pisum sativum (a plant enzyme) have been systemati-
cally compared [26]. Despite this effort, a clear answer con-
cerning the mechanism of PBGS has not been obtained.
At some point during the PBGS-catalyzed reaction a long
chain dicarboxylate intermediate is formed. Here we
describe our studies on the inhibition potency of this type
of compound. To try to distinguish between the two major
mechanistic proposals, diacids containing seven carbon
atoms (suggesting that C–C bond formation occurs first)
[5,14] or diacids containing ten carbon atoms (suggesting
C–N bond formation occurs first) were used [23]. Varying
the chain length should allow the importance of the exact
distance between the two carboxylate ends of the mol-
ecules to be deduced.
The kinetics of PBGS are complex because this enzyme is
a bisubstrate enzyme [29], and understanding the inhibi-
tion behavior of this class of enzymes is often not straight-
forward. The observed kinetics for PBGS under the
standard assay conditions (ALA concentration between
80 and 400 µM), however, must follow the the laws of a
Michaelis–Menten kinetics [30] (Figure 3a).
Results
To explain the kinetic behavior of E. coli PBGS, the
Michaelis constants of each part of the active site were
needed. We calculated these values employing the
Figure 3
Kinetic studies of the formation of PBG
catalyzed by E. coli PBGS. (a) The
Lineweaver–Burk plot shows the results of the
inhibition test using 5-fluorolevulinic acid (6)
as an inhibitor. The plot is characteristic of
competitive inhibition. The KM and Ki values
deduced from these experiments are 50 µM
and 85 µM, respectively. In (b) and (c), the
inverse of the rate of PBG formation (1/V in
min M–1) is plotted against the inverse of the
concentration of the substrate (1/[S] in µM–1)
for two concentration ranges. In (b) the
substrate ranges from 80–400 µM; and in
(c) it ranges from 4–80 µM. For the higher
concentration range (b) a linear relation
between 1/V and 1/[S] is obtained as
expected for a Michaelis–Menten kinetics
(classical Lineweawer–Burk plot). For the
lower concentration range (c) the relationship
is parabolic. The graph shows the best fit to
the following equation: 
(1)
The two Michaelis–Menten constants can be
obtained, and are 4.6 ± 1.9 µM (KM1)
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method used for the D-Ala–D-Ala ligase, another enzyme
that catalyzes the joining of two identical substrates
[31,32]. By working with lower concentrations of the sub-
strate (4–80 µM), we were able to see a significant devia-
tion from the linear dependence predicted by the
Michaelis–Menten kinetics (Figure 3b), and the curve is
best described by second-order kinetics (Figure 3c).
This parabolic curve could be analyzed using nonlinear
regression. The kinetic model used was a steady-state
model based on the sequential formation of two
Michaelis complexes with two different Michaelis con-
stants: KM1 = 4.6 ± 1.9 µM, which corresponds to the sub-
strate tightly bound in the P-site and KM2 = 66 ± 13 µM
for the less well bound substrate in the A-site. This last
value corresponds nicely to the KM determined under
Michaelis–Menten conditions. The second order equa-
tion (see Figure 3) simplifies to a Michaelis–Menten
equation (Figure 4) under standard conditions
([S] = 80–400 µM). The process determining the
observed enzyme kinetics is the formation of the
Michaelis–Menten complex (S.E′) and the formation of
the final product (Figure 4) [9,24,33].
Inhibitors can interact at different steps of the reaction
mechanism [33]. During our inhibition tests it became
clear that significant differences in the kinetic behaviors
are observed for different classes of inhibitors. Very often
the inhibition behavior stays the same for a series of
similar compounds. It is therefore important to determine
whether the inhibition behavior differences can be
explained by differences in sites of interaction in the
enzyme. The large number of inhibitors studied (>121
compounds) allows us to propose a mechanistic interpreta-
tion of the differences in inhibition behavior [34,35].
Substrate and product analogs are often competitive
inhibitors [25]. Competitive inhibition is attributed to a
direct competition between the substrate and the
inhibitor (Figure 5). Under our experimental conditions
direct competition of the substrate analog inhibitors with
the second substrate has to be assumed. The competitive
inhibitors, therefore, have to interact with the A-site of the
enzyme and all variations in their inhibition potency have
to be attributed to differences in recognition of the
enzyme A-site (Figure 5). The substrate analog 6 is obvi-
ously well recognized by this site.
The mechanistic interpretation of the different behaviors
of some of our inhibitors (uncompetitive, irreversible,
mixed or slow-binding inhibition) is less straightforward
than the interpretation of the competitive behavior. We
assume that inhibitors inducing more complex inhibition
behaviors interact with both the A- and P-sites of the
enzyme (one molecule in each site or one molecule inter-
acting in both sites at the same time). In order for the
interaction with the P-site to be kinetically relevant, the
Schiff base formed between the inhibitor and the P-site
lysine residue (Lys247, E. coli numbering) has to be more
stable or at least as stable as the Schiff base formed
between the substrate and Lys247. Under these condi-
tions we will observe mixed inhibition of the free
enzyme (E) and competitive inhibition with the enzyme
linked with the first substrate. This double interaction
leads to complex inhibition behavior; the type observed
depends on the predominance of one or other of the
interactions (Figure 5). Under these experimental condi-
tions the type and the site of interaction of a specific
inhibitor can be deduced from the kinetic data, interpre-
tation of which should allow the correct reaction interme-
diate to be determined.
Figure 4
A kinetic scheme describing the
transformation of two identical substrate
molecules into one product. (a) The part of
the kinetic scheme that is kinetically relevant
when the concentration of the substrate is in
the range of the second Michaelis–Menten
constant KM2. Under these conditions the
P-site of the enzyme is saturated, and
Michaelis–Menten kinetics are observed.
(b) The different forms of the active site of the
enzyme are (from left to right): E, E′ and S·E.
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A series of diacids were tested, under conditions leading to
Michaelis–Menten behavior, as potential intermediates 4
and 5 analogs (Tables 1–4). At first we tested the unfunc-
tionalized diacids pimelic (13) and sebacic acids (17;
Tables 2,3). Almost all of the simple diacids tested showed
competitive inhibition behavior. The inhibition constants
of the competitive inhibitors range from close to 10,000 µM
for fumaric acid (9) to > 20,000 µM for compound 20
Figure 5
A kinetic scheme of PBG biosynthesis is shown in the center. An
inhibitor can interact with the free enzyme E (inhibitor in blue) or with E′
where the P-side is occupied (inhibitor in green). If the inhibitor
interacts, reversibly, only with with the E′ form, pure competitive
inhibition behavior will be observed. Inhibitor interactions will result
from functional groups present at the A-site of the enzyme. If the
inhibitor interacts with the free enzyme E as well as with the ‘mono-
charged’ enzyme E′, the inhibition behavior will be mixed or
uncompetitive depending on the relative inhibition constants at the
P- and A-sites. If the inhibitor forms a stable Schiff base with the
active-site lysine at the P-site, so that the release of the inhibitor
becomes slow, slow-binding inhibition type will be observed. If the
stability of the Schiff base between the inhibitor and the active-site
lysine is so high that the inhibitor is not released any more or if a quasi-
irreversible transformation follows the formation of the Schiff base
(e.g. the formation of enamine tautomer, which can not be protonated
on the enzyme surface) irreversible inhibition will result.
Table 1
Results of the inhibition tests of C4 analogs.
Structure Compound Ki (µM) Type of inhibition
8 12,500 Competitive
9 10,700 Competitive
10 11,500 Competitive
11 12,500 Competitive
12 26,000 Competitive
See the Materials and methods section for details. The inhibition
constants (Ki) were obtained from a series of tests, in which PBGS
was incubated with ALA (80–400 µM) and an adequate amount of the
inhibitor. The amount of product PBG was measured after 14 min
using Ehrlich’s reagent (absorption of the chromophore
ε554nm = 62,000 M–1cm–1). The data were analyzed using the
Lineweaver–Burk procedure to determine the inhibition type (see
Figure 3). The Hanes, Eadie–Hofstee and direct plots were also
analyzed, and the results from all four different methods were in good
agreement. The Ki values reported were obtained from the direct plot.
The KM values obtained from the test reactions in the absence of the
inhibitor were around 50 µM. The KM values were a good indicator of
the activity and the quality of the enzyme used.
Table 2
Results of the inhibition tests of C7 analogs.
Structure Compound Ki (µM) Type of inhibition
13 12,400 Competitive
14 8600 Competitive
rac-15 17,000 Competitive/activator
rac-16 11,900 Competitive/activator
See the Materials and methods section for details. The structures of
the inhibitors are drawn to imitate the proposed key intermediate 5
(see Figure 2) and the analogous intermediate that had been proposed
by Shemin (see Figure 6).
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(Tables 1,3). Much to our surprise there is no significant
difference between fumaric acid (9) and maleic acid (10; as
judged by the inhibition constants). Even the more steri-
cally demanding phthalic acid (11) is in the same range of
inhibition (Table 1). These competitive inhibitors show
only moderate inhibition potency. 
To obtain better recognition at the active site, an addi-
tional keto function was introduced to mimic more closely
the postulated intermediates 4 and 5. It is interesting to
compare pimelic acid (13) with 4-oxo pimelic acid (14;
Table 2). The introduction of a keto group in position 4 in
pimelic acid (13) lowers the Ki value from 12,400 µM to
8600 µM. The most evident difference, however, is
observed between sebacic acid (17) and the 4-oxo sebacic
acid (18; Table 3). In this case the introduction of the keto
function not only improved the Ki value but also changed
of the type of inhibition that occurred. Sebacic acid (17)
showed moderate competitive inhibition (Ki = 8000 µM),
whereas the 4-oxo-sebacic acid (18) became an irreversible
inhibitor. Other cases of irreversible inhibition were found
for compounds 19 and 22 (Table 3). Even after 70 hours of
dialysis the inhibitors could not be removed from the
enzyme (Table 5). 
Diacids with one or two more carbon atoms, such as 27 or
28, show slow-binding inhibition and diacids with one or
two fewer carbon atoms, such as 25 or 26, are good uncom-
petitive inhibitors (Ki values of 80 and 450 µM, respec-
tively; Table 4). In the series of diacids containing ten
carbon atoms, the influence of the introduction of a
Table 3
Results of the inhibition tests of C10 analogs.
Structure Compound Ki (µM) Type of inhibition
17 8000 Competitive/activator
18 (–) Irreversible
19 (–) Irreversible
20 22,900 Competitive
21 8300 Competitive
22 (–) Irreversible
See the Materials and methods section for details. The structures of
the inhibitors are drawn to imitate the proposed key intermediate 4
(see Figure 2), which would be formed as a consequence of a C–N
bond between the two substrates. If an γ-keto function was present (as
in 18 and 22), it was drawn in the position of the P-site of the enzyme
(see Figures 4 and 5). The conformation drawn for 20 is based on the
knowledge that amides will not from amidines (a Schiff base analog) in
the presence of amines in aqueous solution. The amide functional
group was, therefore, drawn on the A-site.
Table 4
Influence of inhibitor chain length on PGBS inhibition potency.
Cx Structure Compound Ki (µM) Type of inhibition
C5 23 8450 Competitive
C6 24 10,400 Competitive
C7 14 8600 Competitive
C8 25 80 Uncompetitive
C9 26 450 Uncompetitive
C10 18 (–) Irreversible
C11 27 (–) Slow binder
C12 28 (–) Slow binder
See the Materials and methods section for details. The inhibitors that
were competitive inhibitors are drawn as analogs of the substrate
incorporated at the A-site of the enzyme (Figures 4,5). Inhibitors that
showed uncompetitive, irreversible or slow-binding behavior are drawn
in conformations that most closely resemble postulated intermediate 4
(see Figure 2). The γ-keto acid part of these inhibitors is always drawn in
the position that corresponds to the P-site of the enzyme (Figures 4,5).
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second keto function (19), as well as one or two nitrogen
atoms (20–22) were investigated (Table 3).
The diacids rac-15 and rac-16 were designed to mimic
more closely the intermediate postulated by Shemin
(Table 2 and Figure 6), and had showed moderate to weak
competitive inhibition behavior (Ki values of 11,900 µM
and 17,000 µM, respectively). Using lower concentrations
of inhibitor and higher concentrations of ALA these com-
pounds activated the enzyme. Testing the two diastere-
omers in their racemic form showed that the ratio between
the inhibition constants was only 1.5. This ratio was more
pronounced when these compounds where tested with
Rhodobacter spheroides PBGS (rac-15 Ki = 11,000 µM and
rac-16 Ki = 25,000 µM).
In view of obtaining compounds which could act as active-
site-directed suicide inhibitors, a series of enantiomeri-
cally pure epoxides (29, 30, 31 and 32) were synthesized
and tested (Figure 7). As expected, all the epoxides inhib-
ited the enzyme irreversibly.
Discussion
The different proposals for the PBGS mechanism postu-
late two structurally different key intermediates (Figure 8)
[3,5,9,14,23,24]. The keto diacid 14 imitates the key inter-
mediate of the Jordan II mechanism, and the keto diacid
18 mimics the key intermediate for the Jordan I mecha-
nism (it is three atoms longer). As our inhibitors are (struc-
turally) highly simplified and because we do not know the
importance of the other functional groups for good recog-
nition, we decided to study a series of keto diacids (23–28)
in addition to the keto diacids 14 and 18, the idea being to
obtain a clearer picture by analyzing the trends instead of
interpreting individual inhibition constants.
If we examine the series of the diacids containing a keto
function (Table 4), we can see a regular change in the
behavior of these compounds with the extension of the
chain length connecting the two diacids. The first deriva-
tives 23, 24 and 14 competitively inhibit the enzyme and
we propose that they are A-site substrate analogs.
Uncompetitive inhibition is observed with the C8 analog,
4-oxo suberic acid (25). This suggests that the inhibitor–
enzyme interaction occurs at both the A- and P-sites simul-
taneously. We can imagine that the chain is long enough to
allow interaction at the two sites, which means that recog-
nition of the two acid functions and formation of the Schiff
base could occur at the same time. This hypothesis of a
Figure 6
Comparison of the two diastereomeric diacids
rac-15 and rac-16 with the intermediate
initially postulated by Shemin, which closely
resembles intermediate 5 (see Figure 2). The
aldol-type reaction (C–C bond formation) that
would lead to this intermediate will create two
chiral centers. Because an enzyme-catalyzed
reaction should follow a diastereoselective
pathway, studying inhibitors that vary the
relative configuration of these two centers
should help to unravel the stereochemical
features of this enzymatic pathway.
Table 5
PBGS activity after incubation with inhibitors showing time-dependent inhibition.
Time-dependence of the activity Dialysis (70 h)
Cx Compound Activity (%) 30 min/90 min Concentration (mM) Recovery (%) after 70 h Concentration (mM) Type of inhibition
C10 22 66/35 0.44 1 2.16 Irreversible
C10 18 73/32 0.41 6 6.70 Irreversible
C10 19 17/6 0.41 1 4.24 Irreversible
C11 27 84/73 0.33 28 3.26 Slow binding
C12 28 46/31 0.45 26 2.55 Slow binding
See the Materials and methods section for details. Enzyme activity was
determined after 30 min respectively 90 min preincubation with the
indicated inhibitor. Significant differences observed as a function of the
preincubation time were interpreted as sign for irreversible or slow-
binding inhibition. To distinguish between these two types of inhibitors,
enzyme activity was determined immediately after the preincubation
with the inhibitor and after 70 hours of dialysis. The activities were
compared with the activity of PBGS preincubated in the absence of
inhibitor. The % recovery of enzyme activity after dialysis is reported,
showing that almost no activity was recovered for 22, 18 and 19. For
27 and 28 ~30% of the activity was recovered.
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better fixation of the inhibitor when the length of the
chain increases is supported by the following results. The
compound 4-oxo azelaic acid (26) is an uncompetitive
inhibitor with inhibition potency comparable to 25. At the
moment we can not unequivocally interpret the slight
increase in the Ki value. The compound 4-oxo-sebacic acid
(18)  inhibits the enzyme irreversibly. This inhibitor con-
tains the γ-keto carboxylic acid unit required for the forma-
tion of the Schiff base at the P-site, as well as a second
carboxylic acid function that can interact with the corre-
sponding surface at the A-site. 18 has the optimal chain
length deduced from the first mechanism postulated by
Jordan. The C11 (27) and C12 (28) analogs are also well rec-
ognized by the enzyme but in these cases, the inhibitors
could be removed from the enzyme by dialysis and are
therefore described as slow-binding inhibitors. 
The most important result of this series is the significant
inhibition difference between 4-oxo pimelic acid (14) and
4-oxo sebacic acid (18), which are structurally related to
the intermediates postulated in the two different mecha-
nisms. To reinforce the results obtained from the series of
keto diacids, we decided to study compounds that more
closely resembled the postulated intermediates.
We initially studied the diacids rac-15 and rac-16
(Figure 6) because they were close analogs of the interme-
diate proposed by Shemin. The amino groups had been
left out in order to avoid unwanted side reactions, and the
methoxy group was a consequence of the synthetic
method used. The incorporation of the methoxy sub-
stituent induces at least two disadvantages: the polarity is
reduced compared with the alcohol and the methoxy
group clearly introduces additional steric hindrance at a
sensitive site of the enzyme–intermediate complex.
The two possible diastereomers were tested separately
using R. spheroides and E. coli PBGSs and showed moder-
ate to weak competitive inhibition behavior. Despite the
more close resemblance of rac-15 and rac-16 to the inter-
mediate postulated by Shemin, their inhibition potency
was diminished compared to the 4-oxopimelic acid (14).
Two conclusions can be drawn from comparing the inhibi-
tion results of the series of diacids separated by eight
atoms (17–22; Table 3). Diacids that do not have a keto
function at one of the γ positions of the carboxylic acids
are only moderately active competitive inhibitors (17, 20
and 21). Replacing the keto function of the analog of
Figure 7
The enantiomerically pure inhibitors 29–32 were synthesized and
studied to examine the enantioselectivity of the PBG biosynthetic
pathway. At the same time the epoxy function was incorporated in
order to trap nucleophiles at the active site of PBGS.
Figure 8
Mechanism proposed for the Zn2+-containing
PBGSs (see text for more details).
(a) A proton shuttle role is assigned to the
second lysine (Lys195) at the active site.
Lys195 is also thought to be involved in the
formation of the Schiff base between the first
substrate and the enzyme, which is required
for the bond-forming process between the
two substrates. (b) The postulated
involvement of Lys195 in the elimination of
Lys247 (V) from the enzyme–substrate
complex and in the final aromatization, which
recreates the enzyme in its native state
(Lys247 neutral and Lys195 in its protonated
form) is shown. Zn2+ might act as a Lewis
acid (not formulated) in order to receive the
hydroxyl group (II) and then as a base (II→III).
The nature and the recreation of the base (B–)
required for IV→V reaction is not yet clear.
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intermediate 18 by an amide yields the weakest inhibitor
of the whole series. The amide function will not form a
Schiff base with the active-site lysine. The lack of reac-
tivity of the carbonyl group allows us to rationalize easily
the reduced inhibition potency and the different inhibi-
tion behavior. 
Inhibitors 29, 30, 31 and 32 were synthesized and tested to
try and irreversibly trap reactive sidechains at the active
site of the enzyme. To induce the aldol-type reaction,
double activation by a Lewis acid on the P-site and by a
base on the A-site seems to be reasonable. This combina-
tion of active groups would be ideally suited to activating
an epoxy group. All compounds showed a moderate time-
dependent inhibition. The relatively weak inhibition of
these compounds can be interpreted as the consequence
of an unfavorable arrangement of the functional groups or
of a weak recognition of these inhibitors at the active site.
On the basis of our inhibition results and incorporating the
information from the X-ray structures [17–20], the follow-
ing mechanism can be proposed for PBGS (Figure 8).
The formation of the Michaelis–Menten complex
between the carbonyl of the substrate and Lys247 at the
P-site of the enzyme is the first step. As shown by
Shoolingin-Jordan and coworkers [17], a second lysine
(Lys195) in the active site seems to be important for the
formation of the Schiff base (I; Figure 8a). In this mecha-
nistic proposal, we assign a proton donor or acceptor role
to Lys195 during formation of the Schiff base. Then the
second substrate joins the complex, forming the second
Michaelis–Menten complex at the A-site. At this stage,
formation of the carbon–nitrogen bond between the two
substrates occurs via a Schiff base (II; Figure 8b). The
Schiff base has to be transformed into enamine III for
carbon–carbon bond formation to take place. The exact
conformation of the intermediate required to activate the
aldol-type reaction is not known. To bring the nucle-
ophilic and electrophilic centers close enough together for
the bond-forming process, the two halves of the molecule
have to be twisted considerably to allow a sufficient
overlap between the active centers of the enamine at the
A-site and the iminium ion at the P-site. Deprotonation to
the iminium ion IV forming the enamine V, followed by
elimination of the amino group of the active-site Lys247
and by deprotonation (possibly by Lys195) seems to be a
plausible sequence leading to porphobilinogen (1). 
Significance
Porphobilinogen synthnase (PBGS) is an important
enzyme involved in the biosynthesis of tetrapyrrolic
cofactors. PBGS catalyzes the joining of two molecules
of 5-aminolevulinate (ALA) by forming a carbon
heteroatom bond as well as a carbon–carbon bond.
Uncatalyzed dimerization of ALA leads, in most cases,
to a different product. It is important, therefore, to
understand in detail the mechanism that distinguishes
the biosynthesic reaction from the chemical transforma-
tion. One of the central questions is whether C–C or
C–N bond formation occurs first.
The PBGS active site is composed of two sites where the
two substrates bind. Using kinetic studies, we were able
to estimate the Michaelis constants for each site, which
were 4.6 µM for the P-site (KM1) and 66 µM for the
A-site (KM2). We examined the kinetic behavior of
PBGS systematically using different classes of
inhibitors. Substrate analogs are competitive inhibitors
that compete directly with binding of the second sub-
strate at the A-site. Inhibitors that interact with both the
A- and P-sites of the enzymes have more complex
kinetic behavior. We studied series of carboxylic diacids
to learn more about the factors responsible for substrate
recognition at the active site of PBGS. An interesting
chain-length dependence was observed in a series of
homologous γ ketodiacids. Starting with keto glutaric
acid, the inhibition changed from competitive to uncom-
petitive for keto suberic and keto azelaic acid and
changed again to irreversible for keto sebacic acid.
Slow-binding inhibition was observed for the longest
homologs. γ-Keto sebacic acid is the unique irreversible
inhibitor in this series. These  results allowed us to
define a new class of irreversible inhibitors of the
Escherichia coli PBGS. These inhibitors are carboxylic
diacids separated by eight atoms that contain at least one
keto function in the γ position of one acid functional
group. With respect to the PBGS mechanism, our
results strongly support the Jordan I mechanism (shown
in Figure 2), in which C–N bond formation occurs first.
Materials and methods
Chemistry
Chemicals (Fluka or Aldrich) and solvents (Fluka, puriss) were used
without further purification. Proton magnetic resonance spectra: Bruker
AMX-400 (1H: 400 MHz, 13C: 100 MHz), Bruker AM 360 (1H: 360
MHz, 13C 90 MHz); chemical shifts δ are reported in ppm relative to
tetramethylsilane; coupling constant J in Hz; solvent CDCl3. EI-MS (70
eV): Nermag RC 30-10. FAB-MS (glycerine, Argon): VG Micromass
7070 E. HR-MS: Bruker FTMS 4.7T BioAPEX II (ESI(positive)-MS).
[α]: Jasco J-710 spectropolarimeter. Elemental analyses were per-
formed by the Microanalytical Laboratory of Ciba-Specialties SA, Marly
(Switzerland). For flash column chromatography (FCC) carried out at
~0.2 bar, silica gel 60 (0.04–0.063 mm; Fluka) was used.
Tested compounds
Succinic acid (8), fumaric acid (9), maleic acid (10), phthalic acid (11), 2-
nitrobenzoic acid (12), 2-oxoglutaric acid (23), 3-oxoadipic acid (24),
pimelic acid (13), 4-oxopimelic acid (14), and sebacic acid (17) are com-
mercially available. 4-oxosebacic acid (18) [36,37], 4,7-dioxosebacic
acid (19) [38] and N,N′-disuccinylhydrazine (21) [39] were synthesized
according to the literature and their spectroscopic data were consistent
with previous reports. N-succinyl-5-aminolevulinic acid (22) [40] was
obtained by hydrogenolysis of the corresponding dibenzyl ester synthe-
sized by coupling of monobenzyl succinate with benzyl 5-aminolevulinate
tosylate salt. 4-oxosuberic acid (25) [41] and 4-oxoazelic acid (26) [42]
were obtained by acid or base hydrolysis of the corresponding diesters.
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Those diesters [37,43] were synthesized by the coupling of the respec-
tive organozinc ester with 3-methoxycarbonylpropionyl chloride following
a procedure of Rieke and co-workers [44,45]. 4-oxoundecandioic acid
(27) [46] and 4-oxododecandioic acid (28) [47] were obtained by acid
hydrolysis of the corresponding diesters. Those diesters [48] (ethyl
10-methoxycarbonyl-4-oxodecanoate 92% (GC), HR-MS (C14H24NaO5):
295.1514 (calc’d 295.1516) were synthesized by alkylation and acyla-
tion of dibenzyl malonate with ethyl bromoacetate and the respective acyl
chloride methyl ester then hydrogenolysis and decarboxylation in analogy
to the procedure of Naora et al. [49]. 
(rac)-(3R,4S)-3-acetyl-4-methoxy-4-methylpimelic acid (16). Following
the procedure of Bertschy et al. [50] for the Mukaiyama aldol coupling
[51] of methyl 4-trimethylsilyloxy-3-pentenoate [50] and methyl levulinate
dimethylacetal [52] led to 75% yield of the diastereoisomeric mixture
(the ratio of (rac)-RR-15:(rac)-RS-16 diesters was 1.7:1). Diasereoiso-
mers were separated by FCC (hexane-ethyl acetate 4:1) yielding 39%
of (rac)-RR-15 diester and 17% of (rac)-RS-16 diester.
Hydrolysis of (rac)-RS-16 diester (1.4 g, 5.1 mmol) was undertaken in a
2:1 mixture of aqueous NaOH 0.5 M/THF (150 ml) for 3 h at room tem-
perature. The reaction mixture was extracted once with diethylether
(80 ml) then acidified with 4 M HCl to pH 2, saturated with NaCl and
extracted with diethylether (6 × 100 ml). The organic layers were
washed once with brine, dried over MgSO4 and evaporated. The crude
product (1.3 g) was crystallized in THF/hexane to yield 760 mg (61%)
of white solid product. M.p. 92–93°C. IR (KBr) 3600–2300s (br.),
1715s, 1435s, 1405s, 1380s, 1360s, 1350s, 1300s, 1250s, 1215m,
1170s, 1130s, 1120s, 1090m, 1065m, 975m, 925m, 880m. 1H-RMN
δ 3.40 (dd, 3J 11.4, 3J 2.8, 1H, HC(3)), 3.21 (s, 3H, H3CO), 2.93 (dd,
2J 17.6, 3J 11.4, 1H, HC(2)), 2.54 (dd, 2J 17.6, 3J 2.8, 1H, HC(2)),
2.49–2.38 (m, 2H, H2C(6)), 2.32 (s, 3H, Ac), 1.94 (ddd, 2J 14.7, 3J 9.7,
3J 5.8, 1H, HC(5)), 1.75 (ddd, 2J 14.7, 3J 10.0, 3J 6.2, 1H, HC(5)), 1.13
(s, 3H, H3CC(4)). 13C-RMN 209.9 C(4), 179.5, 178.6 C(1), C(7), 76.5
C(4), 52.8 C(3), 49.0 CH3O, 32.8 CH3(Ac), 32.4 C(2), 30.8 C(6), 28.1
C(5), 19.8 CH3C(4). FAB-MS 249 (1), 248 (3), 247 (18, [M+H]+), 215
(10), 197 (8), 155 (40), 137 (28), 131 (55), 127 (30), 109 (19), 99
(100), 85 (45), 71 (16), 55 (19), 43 (100). Anal. calc’d for C11H18O6
(246.26): C 53.65, H 7.37; found: C 53.71, H 7.32. The same condi-
tions were used for the hydrolysis of the major diastereomers.
(3R,4S)-3,4-epoxy-6-nitro-2-hexanone (30). Using Sharpless epoxidation
conditions [53,54] on (rac)-6-bromo-3-hexen-2-ol, (SSS)-6-bromo-3,4-
epoxy-2-hexanol was obtained in 29% yield and was converted by Swern
oxidation in (3R,4S)-6-bromo-3,4-epoxy-2-hexanone in 74% yield [55]. 
A suspension of (3R,4S)-6-bromo-3,4-epoxy-2-hexanone (158 mg,
0.82 mmol) and AgNO2 (163 mg, 1.06 mmol) in hexane (20 ml) was
refluxed for 3 h. The reaction mixture was filtered and the filtrate evapo-
rated. The crude product (114 mg) was purified by FCC (heptane-ethyl
acetate 4:1) to yield 64 mg (49%). IR (film) 3013w, 2924w, 1713s,
1555s, 1434m, 1381s, 1363s, 1252m, 871m, 758m. 1H-RMN δ 4.55
(ddd, 2J 13.8, 3J 8.2, 3J 5.6, 1H, HC(6)), 4.54 (dt, 2J 13.8, 3J 6.3, 1H,
HC(6)), 3.28–3.24 (m, 2H, HC(3), HC(4)), 2.53 (ddddd, 2J 15.2, 3J
7.9, 3J 6.5, 3J 4.1, 4J 1.4, 1H, HC(5)), 2.15 (dq, 2J 15.2, 3J 6.1, 1H,
HC(6)), 2.09 (s, 3H, H3C(1)). 13C-RMN 205.0 C(2), 72.1 C(6), 59.9
C(3), 55.0 C(4), 29.8 C(5), 25.3 C(1). EI-MS 160 (<1, [M+H]+), 159
(<1, [M]+), 116 (19), 85 (9), 43 (100), 41 (19), 30 (11).
[α]D298 = +14.22° (CH2Cl2, c = 0.696). Anal. calc’d for C6H9NO4
(159.14): C 45.28, H 5.70, N 8.80; found: C 44.72, H 5.63, N 9.25.
Methyl (4S,5R)-epoxy-4-methyl-6-oxooctanoate (32). Starting from the
geraniol, (4S,5R )-epoxy-4-methyl-6-oxooctanal was obtained by Sharp-
less epoxidation followed by Swern oxidation of the alcohol function,
attack of the resulting aldehyde with MeLi, then Swern oxidation and
finally by ozonolysis of the double bond with an overall yield of 28% [55].
A solution of (4S,5R )-epoxy-4-methyl-6-oxooctanal (1.02 g, 6.56 mmol)
in methanol (1.26 g, 39.4 mmol) was stirred at room temperature for
15 min. DMF (20 ml) and PDC (14.8 g, 39.4 mmol) were added (water
bath cooling) and the reaction mixture was stirred 18 h at room tempera-
ture before being worked up with water (300 ml) and extracted with
ethyl acetate (6 × 50 ml). The organic layers were washed with 0.1 M
HCl (200 ml), 1% NaHCO3 (200 ml), dried over MgSO4, filtered and
evaporated to yield 668 mg (55%) of liquid product. IR (film) 2955m,
1738s, 1439m, 1407m, 1386m, 1359m, 1297m, 1195s, 1089m,
840m. 1H-RMN δ 3.69 (s, 3H, H3CO), 3.42 (s, 1H, HC(5)), 2.41 (t, 3J
7.6, 2H, HC(2)), 2.21 (s, 3H, H3C(7)), 2.00 (dt, 2J 14.3, 3J 7.2, 1H,
HC(3)), 1.99 (dt, 2J 14.3, 3J 7.9, 1H, HC(3)), 1.25 (s, 3H, H3CC(4)).
13C-RMN 204.6 C(6), 173.6 C(1), 65.1 C(5), 62.9 C(4), 52.5 CH3O,
33.4 C(3), 30.0 C(2), 28.6 C(7), 17.0 CH3C(4). EI-MS 187 (100,
[M+H]+), 169 (16), 155 (6), 145 (15), 127 (10), 113 (9), 99 (15). Anal.
calc’d for C9H14O4 (186.21): C 58.05, H 7.58; found: C 57.81, H 7.63.
Materials
E. coli (CR 261) was a gift from C. Roessner of Texas A&M University.
Production of E. coli and purification of PBGS have been described
previously [15].
PBGS assay and determination of kinetic constants 
The PBGS assay is a colorimetric assay based on the reaction
between PBG and 4-dimethylaminobenzaldehyde [56], the so-called
Ehrlich’s reagent.
The assay for E. coli PBGS contained 4–6.4 µg PBGS, the inhibitor in
1.5 ml of 0.1 M NaP (NaH2PO4-Na2HPO4 mixture) (pH = 8.1, 12.3 mM
mercaptoethanol, 10 mM MgCl2
.6H2O and 10 µM ZnCl2). The preincu-
bation took place at 37° for 30–45 min. The substrate was added in
varying concentrations and the solution was incubated for 14 min,  after
which the PBGS-catalyzed reaction was stopped by adding 1 ml of the
stop reagent (20% TCA, 10 mM HgCl2) at 0°C. After centrifugation
(4 min, 3600 g) 1 ml of the supernatant was treated with 1 ml of Ehrlich’s
reagent (4-dimethylaminobenzaldehyde in perchloric acid 70%/acetic
acid solution). This solution was centrifuged (4 min, 3,600 g) for a
second time. The quantity of product formed was determined by measur-
ing the absorbance at 554 nm (ε = 62,000 [mol–1 cm1]).
The type of inhibition was determined using Eadie–Hofstee,
Lineweaver–Burk and Hanes plots. The Ki values shown in the different
tables are the average of at least three independent assays. Ki values
were calculated from the apparent KM deduced from the hyperbolic
plot, typical for Michaelis–Menten kinetics.
Calculation of the kinetic constants KM1 and KM2
400 µl of a solution containing 1.1 mg of PBGS diluted in 70 ml of
phosphate buffer (0.1M NaP, at pH = 8.1, 12.3 mM mercaptoethanol,
10 mM MgCl2
.6H2O and 10 µM ZnCl2) was added to (1100–X) µl of
phosphate buffer (X = 20, 40, 60, 80, 100, 200, 300 or 400 µl).The
different tubes were preincubated 15 min at 37°. After addition of X µl
of ALA solution (0.5 mg/ml for assay (a) and 0.05 mg/ml for assay (b)),
the tubes are incubated for 14 min. The PBGS-catalyzed reaction was
then stopped by adding 1 ml of the stop reagent at 0°C. After centrifu-
gation (4 min, 3600 g) 1 ml of the supernatant was treated with 1 ml of
Ehrlich’s reagent. This solution was centrifuged (4 min, 3,600 g) for a
second time. The quantity of product formed was determined by mea-
suring the absorbance at 554 nm (ε = 62,000 [mol–1 cm1]; Table 5).
The Lineweaver–Burk plot (1/v against 1/[S] was used to deduce the
two Michaelis constants of each site using nonlinear regression (see
Figure 3).
Estimation of the specific activity
Protein concentration was estimated by the Bio-Rad Protein Assay
using the color change of the Coomassie Brilliant Blue-G-250. This
color change is followed by measuring the absorbance at 596 nm [57].
The concentration of our protein is deduced by comparison with a
standard curve. Using this value together with the rate of PBG forma-
tion allows the specific activity to be calculated.
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Dialysis assay
4–6.4 µg PBGS were dissolved in 10 ml phosphate buffer (0.1M NaP,
pH = 8.0, 12.3 mM mercaptoethanol, 10 mM MgCl2
.6H2O and 10 µM
ZnCl2). 4 ml of this solution was placed in two different 5 ml tubes, one
containing 5.8 mg of 4-oxo-sebacic acid (19) and the second (without
inhibitor) was used as a reference. After 24 h at room temperature, the
specific activities were determined. The solution containing the inhibitor
showed only 22.4% of the specific activity compared to the blank
experiment. 1 ml of each solution was placed in a dialysis tube and
separately dialyzed against 2.5 l phosphate buffer solution (0.1 M NaP,
pH = 8.0, 12.3 mM mercaptoethanol, 10 mM MgCl2
.6H2O and 10 µM
ZnCl2). After 66 h dialysis at 4°C, the specific activities were again
determined (the solution initially containing the inhibitor showed 28.5%
of the specific activity compared to the blank experiment). The same
measurements were repeated with compounds 19, 22, 27 and 28
(Table 6).
Acknowledgements
We thank the Swiss National Science Foundation and the Foundation of the
Basel Chemical Industry for financial support of our work.
References
1. Battersby, A.R., Fookes, C.J.R., Matcham, G.W.J. & McDonald, E.
(1980). Biosynthesis of the pigments of life: formation of the
macrocycle. Nature 285, 17-21.
2. Shemin, D. (1970). δ-Aminolevulinic acid dehydratase
(Rhodopseudomas spheroides). Methods Enzymol. XVII Part
A, 205-211.
3. Cheh, A.M. & Neilands, J.B. (1976). The δ-aminolevulinate
dehydratases: molecular and environmental properties. In Bonding
and Structure. pp.123-169, Springer-Verlag, Berlin. 
4. Leeper, F.J. (1989). The biosynthesis of porphyrins, chlorophylls and
vitamin B12. Nat. Prod. Rep. 6, 171-203.
5. Jordan, P.M. (1991). The biosynthesis of 5-aminolaevulinic acid and its
transformation into uroporphyrinogen III. In Biosynthesis of
Tetrapyrroles. (Jordan, P.M., ed.) pp.1-66, Elsevier, Amsterdam. 
6. Franck, B. & Stratmann, H. (1981). Condensation products of the
porphyrin precursor 5-aminolevulinic acid. Heterocycles 15, 919-923.
7. Scott, I.A., Townsend, C.A., Okada, K. & Kajiwara, M. (1973).
Concerning the biosynthesis of vitamin B12. Trans. N.Y. Acad. Sci.
35, 72-79.
8. Butler, A.R. & George, S. (1992). The nonenzymatic cyclic
dimerisation of 5-aminolevulinic acid. Tetrahedron 48, 7879-7886.
9. Neier, R. (1996). Chemical synthesis of porphobilinogen and studies of
its biosynthesis. In Advances in Nitrogen Heterocycles. (Moody, C.J.
ed.) pp.35-146, JAI Press Inc., Greenwich, Connecticut. 
10. Nandi, D.L. & Shemin, D. (1968). δ-Aminolevulinic acid dehydratase of
Rhodopseudomonas spheroides. II. Association to polymers and
dissociation to subunits. J. Biol. Chem. 243, 1231-1235.
11. Echelard, Y., Dymetryszyn, J., Drolet, M. & Sasarman, A. (1988).
Nucleotide sequence of the hemB gene of Escherchia coli K12. Mol.
Gen. Genet. 214, 503-508.
12. Jaffe, E.K. (1995). Porphobilinogen synthase, the first source of
heme’s asymmetry. J. Bioenerg. Biomembr. 27, 169-179.
13. Gibbs, P.N.B. & Jordan, P.M. (1986). Identification of lysine at the
active site of human 5-aminolaevulinate dehydratase. Biochem. J.
236, 447-451.
14. Nandi, D.L. & Shemin, D. (1968). δ-Aminolevulinic acid dehydratase of
Rhodopseudomonas spheroides, III. Mechanism of porphobilinogen
synthesis. J. Biol. Chem. 243, 1236-1242.
15. Mitchell, L.W. & Jaffe, E.K. (1993). Porphobilinogen synthase from
Escherichia coli is a Zn(II) metalloenzyme stimulated by Mg(II). Arch.
Biochem. Biophys. 300, 169-177.
16. Petrovich, R.M., Litwin, S. & Jaffe, E.K. (1996). Bradyrhizobium
japonicum porphobilinogen synthase uses two Mg(II) and monovalent
cations. J. Biol. Chem. 271, 8692-8699.
17. Erskine, P.T., et al., & Cooper, J.B. (1997). X-ray structure of
5-aminolaevulinate dehydratase, a hybrid aldolase. Nat. Struct. Biol.
4, 1025-1031.
18. Erskine, P.T., et al., & Cooper, J.B. (1999). The Schiff base complex of
yeast 5-aminolaevulinic acid dehydratase with laevulinic acid. Protein
Sci. 8, 1250-1256.
19. Erskine, P.T., et al., & Shoolingin-Jordan, P.M. (1999). X-ray structure
of 5-aminolevulinic acid dehydratase from Escherichia coli complexed
with the inhibitor levulinic acid at 2.0 Å resolution. Biochemistry
38, 4266-4276.
20. Frankenberg, N., Erskine, P.T., Cooper, J.B., Shoolingin-Jordan, P.M.,
Jahn, D. & Heinz, D.W. (1999). High resolution crystal structure of a
Mg2+ dependent porphobilinogen synthase. J. Mol. Biol. 289, 591-602.
21. Sundberg, R.J. (1996). Pyrroles and their benzo derivatives: synthesis.
In Comprehensive Heterocyclic Chemistry. (Katritzky, A.R., Rees, C.W.
& Scriven, E.F. eds) pp. 275-321, Elsevier Science Ltd., Oxford, UK.
22 Abeles, R.H., Frey, P.A. & Jencks, W.P. Nitrogen metabolism: amino
acids, urea, and heme. In Biochemistry. (pp.714-717), Jones and
Bartlett Publishers, Boston.
23. Jordan, P.M. & Seehra, J.S. (1980). Mechanism of action of
5-aminolevulinic acid dehydratase: stepwise order of addition of the
two molecules of 5-aminolevulinic acid in the enzymic synthesis of
porphobilinogen. J. Chem. Soc. Chem. Commun., 240-242.
24 Granick, S. & Mauzerall, D. (1958). Porphyrin biosynthesis in
erythrocytes. II. Enzymes converting δ-aminolevulinic acid to
coproporphyrinogen. J. Biol. Chem. 232, 1119-1140.
25. Lüönd, R.M., Walker, J. & Neier, R.W. (1992). Assessment of the
active-site requirements of 5-aminolaevulinic acid dehydratase:
Evaluation of substrate and product analogues as competitive
inhibitors. J. Org. Chem. 57, 5005-5013.
26. Senior, N.M., et al., & Warren, M.J. (1996). Comparative studies on the
5-aminoleavulinic acid dehydratases from Pisum sativum, Escherichia
coli and Saccharomyces cerevisiae. Biochem. J. 320, 401-412.
27. Cheung, K-M., Spencer, P., Timko, M.P. & Shoolingin-Jordan, P.M.
(1997). Characterization of a recombinant pea 5-aminolevulinic acid
dehydratase and comparative Inhibition studies with the Escherichia
coli dehydratase. Biochemistry 36, 1148-1156.
28. Appleton, D., Duguid, A.B., Lee, S-K., Ha, Y-J., Ha, H-J. & Leeper, F.J.
(1998). Synthesis of analogues of 5-aminolaevulinic acid and
inhibition of 5-aminolaevulinic acid dehydratase. J. Chem. Soc. Perkin.
Trans. 1, 89-101.
29. Cornish-Bowden, A. & Wharton, C.W. (1990). Reactions of two
substrates. In Enzyme Kinetics. (Rickwood, D. & Male, D. eds),
pp.25-33, IRL Press Limited, Oxford. 
Table 6
Determination of the two Michaelis constants KM1 and KM2.
(a) Concentration of 5-aminolevulinic acid between 80 and 400 µM.
Concentration of ALA (µM) Absorbance Rate (µM min–1)
79.58 0.396 1.522
99.48 0.425 1.632
119.37 0.459 1.762
159.16 0.500 1.920
198.95 0.526 2.022
397.91 0.595 2.285
(b) Concentration of 5-aminolevulinic acid between 4 and 80 µM.
Concentration of ALA (µM) Absorbance Rate (µM min–1)
3.97 0.025 0.096
7.95 0.060 0.230
11.91 0.091 0.349
15.89 0.124 0.476
19.85 0.152 0.584
39.70 0.288 1.106
59.55 0.358 1.375
74.40 0.412 1.582
Figures 3b,c present these results graphically. The rate (v) is
calculated using the following equation:
v = (n [factor dilution]•Abs•106)/(e•l [cell length]•t[ incubation time])
cm7305.qxd  03/10/2000  11:36  Page 195
11
30. Michaelis, M. & Menten, M.L. (1913). Die kinetik der invertinwirkung.
Kinetics of the action of invertine [Kinetics of the action of invertine].
Biochem. Z. 49, 333-369.
31. Neuhaus, F.C. (1962). The enzymatic synthesis of D-alanyl–D-alanine.
J. Biol. Chem. 237, 3128-3135.
32. Zawadzke, L.E., Bugg, T.D.H. & Walsh, C.T. (1991). Existence of two
D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing
of the ddlA gene and purification and characterization of the DdlA and
DdlB enzymes. Biochemistry 30, 1673-1682.
33. Tschudy, D.P., Hess, R.A. & Frykholm, B.C. (1981). Inhibition of
δ-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid. J. Biol.
Chem. 256, 9915-9923.
34. Henz, M. (1996). Inhibitionsstudien zum mechanismus der
porphobilinogen synthase isoliert aus Escherichia coli CR 261
[Inhibition studies of porphobilinigen synthase isolated from
Escherichia coli 261 in view of elucidating the mechanism of PBGS]
[PhD thesis]. University of Neuchâtel.
35. Jarret, C. (1999). Etude de la porphobilinogène synthase
d’Escherichia coli: inhibition sélectives des deux sites actifs [Studies
of Escherichia coli porphobilinogen synthase: directed site selective
inhibition] [PhD thesis]. University of Neuchâtel.
36. Hünig, S. & Lücke, E. (1959). Kettenverlängerung von dicarbonsäuren
um 6 und 12 C-atome. [Chain elongation of dicarboxylic acids by 6
and 12 C-atoms.] Chem. Ber. 92, 652-662.
37. Zürcher, A. & Hesse, M. (1987). Die oxidation von 3-(1-nitro-2-
oxocycloalkyl)propanal [Oxidation of 3-(1-nitro-2-
oxocycloalkyl)propanal]. Helv. Chim. Acta 70, 1937-1943.
38. Diels, O. & Alder, K. (1931). Synthesen in der hydroaromatischen
reihe; ‘dien-synthesen’ mit pyrrol und seinen homologen [Synthesis in
the field of hydrogenated aromoatic rings; ‘diene-synthesis’ using pyrol
and its homologs]. Justus Liebigs Ann. Chem. 486, 211-225.
39. Feuer, H., Bachman, G.B. & White, E.H. (1951). The reaction of succinic
anhydride with hydrazine hydrate. J. Am. Chem. Soc. 73, 4716-4719.
40. Neuberger, A. & Scott, J.J. (1954). The synthesis of
δ-succinamidolævulic acid and related compounds. J. Chem. Soc.
1820-1825.
41. Heller, J., Yogev, A. & Dreiding, A.S. (1972). Bishomochinon.
[Bishomoquinone.] Helv. Chim. Acta 55, 1003-1025. 
42. Kostova, K. & Hesse, M. (1984). γ-Nitro-γ-butyrolacton [γ-Nitro-
γ-butyrolactone]. Helv. Chim. Acta 67, 1725-1728. 
43. Rieke, R.D., Wehmeyer, R.M., Wu, T.C. & Ebert, G.W. (1989). New
organocopper reagents prepared utilizing highly reactive copper.
Tetrahedron 45, 443-454.
44. Zhu, L., Wehmeyer, R.M. & Rieke, R.D. (1991). The direct formation of
functionalized alkyl(aryl)zink halides by oxidative addition of highly
reactive zinc with organic halides and their reactions with acid
chlorides, α,β-unsaturated ketones, and allylic, aryl and vinyl halides.
J. Org. Chem. 56, 1445-1453.
45. Guijarro, D., Rosenberg, D.M., Rieke, R.D. (1999). The reaction of active
zinc with organic bromides. J. Am. Chem. Soc. 121, 4155-4167.
46. Finch, N., Fitt, J.J. & Hsu, I.H.C. (1971). Cyclopentenone synthesis by
directed cyclization. J. Org. Chem. 36, 3191-3196.
47. Serebryakov, E.P., Simolin, A.V., Kucherov, V.F. & Rozynov, B.V. (1970).
New metabolites of Fusarium moniliform. Tetrahedron 26, 5215-5223.
48. Sharma, K.K. & Torssell, K.B.G. (1984). New routes to γ-ketoesters,
β-hydroxy-δ-ketoesters, α,β-unsaturated γ-ketoaldehydes and acetals.
Synthesis of cyclopentenones. Tetrahedron 40, 1085-1089.
49. Naora, H., Ohnuki, T. & Nakamura, A. (1988). An improved synthesis
of methyl 7-(2-hydroxy-5-oxo-1-cyclopentenyl)heptanoate. Bull. Chem.
Soc. Jpn. 61, 993-994.
50. Bertschy, H., Meunier, A. & Neier, R. (1990). A new pyrrole synthesis.
Angew. Chem. Int. Ed. Engl. 29, 777-778.
51. Mukaiyama, T. (1982). The directed aldol reaction. Org. React.
28, 203-331.
52. Meister, C. & Scharf, H.D. (1983). Synthese von (1s)-(-)-frontalin
[Synthesis of (1s)-(-)-frontaline]. Liebigs Ann. Chem. 913-921.
53. Johnson, R.A. & Sharpless, K.B. (1991). Addition reactions with
formation of carbon-oxygen bonds: (ii) Asymmetric methods of
epoxidation. In Comprehensive Organic Synthesis. Vol. 7 Oxidation.
(Trost, B.M. ed.), pp. 389-436, Pergamon Press, Oxford, UK.
54. Carlier, P.R., Mungall, W.S., Schröder, G. & Sharpless, K.B. (1988).
Enhanced kinetic resolution and enzyme-like shape selectivity. J. Am.
Chem. Soc. 110, 2978-2979.
55. Marty, M. (1995). Synthese von enantiomerenreinen analoga eines
möglichen zwischenproduktes der PBG biosynthese [Chain
elongation of dicarboxylic acids by 6 and 12 C-atoms] [PhD thesis].
University of Neuchâtel.
56. Mauzerall, D. & Granick, S. (1956). The occurence and determination
fo δ-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem.
219, 435-446.
57. Bradford, M.M. (1977). A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the principle of
protein-dye binding. Anal. Biochem. 72, 248-254.
cm7305.qxd  03/10/2000  11:36  Page 196
12
